Streetbeat News

Products Services

HUGE

FSD Pharma announced that Celly Nu has entered into a strategic partnership with Six+One for the beverage product unbuzzd, which uses FSD Pharma's licensed technology to relieve the effects of alcohol. FSD Pharma will receive royalties from sales of products using this technology.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 11:58 am

TSCO

Tractor Supply reported a 1.1% increase in Q1 comparable store sales, driven by a 1.3% increase in transaction count, offset by a 0.2% decline in average ticket size. The growth was attributed to strong seasonal merchandise sales, balanced by declines in year-round discretionary categories. Consumables, usables, and edibles aligned with the overall sales performance.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 11:58 am

VRAX

Virax Biolabs announced to Benzinga the launch of ViraxImmuneTM, marking a significant milestone towards its commercialization as a full In-Vitro-Diagnostic product.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 11:52 am

VRAX

Virax Biolabs has announced the launch of a new portfolio of immune profiling solutions aimed at evaluating adaptive immunity in post-viral syndromes. This development could position Virax Biolabs as a key player in the post-pandemic healthcare landscape, focusing on long-term immune health.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 11:51 am

SPNS

Sapiens International Corporation has released an updated version of its reinsurance and analytics solution, aimed at improving operational efficiency, regulatory reporting, and strategic decision-making through enhanced business insights. This update is designed to meet the evolving demands of the market.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 11:48 am

LODE

Comstock has successfully completed the commissioning stages of its demonstration-scale production facility located in Silver Springs, Nevada. This marks a significant milestone for the company as it advances towards full-scale production.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 11:47 am

VRAX

Virax Biolabs Group Limited (NASDAQ: VRAX) announced the launch of ImmuneSelect, a new portfolio within the ViraxImmune T-Cell diagnostic platform for research-use-only, aimed at evaluating adaptive immunity in post-viral syndromes. The announcement was made at the European Society of Clinical Microbiology and Infectious Diseases Global 2024 Congress. ImmuneSelect is designed to aid in the understanding and early characterization of symptoms associated with post-viral syndromes, including Long COVID, through T-Cell driven immunity evaluation. The portfolio includes peptide pools for various pathogens and recombinant antibodies targeting cytokines and biomarkers.

Portfolio Pulse from Vandana Singh

April 25, 2024 | 11:45 am

STRM

Streamline Health is expanding its partnership with a 5-facility, 700-bed health system using Oracle EHR, by adding eValuator's code auditing technology to enhance pre-bill revenue integrity. This comes after more than 2 years of the health system using Streamline's RevID for automated charge reconciliation.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 11:44 am

PLUG

Plug Power has signed two new contracts to deliver Basic Engineering and Design Packages (BEDP) for projects in Europe and the US, increasing its global BEDP contracts to 4.5GW. With 50MW of its electrolyzers already operational, Plug is on track to become the world's largest provider of PEM technology by year-end.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 11:42 am

SNGX

Soligenix has expanded its patent protection for its Filovirus vaccine platform, including thermostabilized Ebola vaccines MarVax and SuVax, to the UK and South Africa. The extension also covers a nanoemulsion adjuvant compatible with lyophilization.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 11:40 am